FMC|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0.11 | - | - |
| Q2'26 | $0.23 | $0.26 | +15.2% |
| Q1'26 | $-0.34 | $-0.23 | +31.4% |
| Q4'25 | $1.21 | $1.20 | -1.2% |
| Q3'25 | $0.85 | $0.89 | +4.1% |
| Q2'25 | $0.62 | $0.69 | +11.2% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $867M | - | - |
| Q2'26 | $914M | $841M | -8.0% |
| Q1'26 | $752M | $759M | +0.9% |
| Q4'25 | $1.2B | $1.1B | -6.8% |
| Q3'25 | - | $542M | - |
| Q2'25 | - | $1.1B | - |
Market Data
FMC Stock Snapshot
FMC is currently trading at $10.60, giving FMC Corporation a market cap of 1.34B. Today's range spans $10.53–$10.82, with shares opening at $10.63 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 23/100 (SELL) with a news sentiment reading of 58/100.
Over the past year FMC has traded between $9.95 and $40.84 - the current price is +6.5% off the 52-week low and -74.0% from the high.
Sector laggard risk is elevated for FMC Corporation (FMC): small-cap, Basic Materials, 1.34B market cap, 23/100 (SELL), sentiment neutral at 58/100. Price: $10.60 (near 52-week lows). When the broader Basic Materials sector outperforms but a small-cap constituent can't produce better than a SELL read, company-specific issues - rather than macro tailwinds - are the primary driver. Annual range: $9.95–$40.84. Identifying those company-specific factors is the key analytical task in the current setup.
The absence of strong institutional sponsorship makes FMC's SELL signal (23/100) more consequential than the same signal in a larger name — at 1.34B in Basic Materials market cap, there are fewer natural buyers to absorb selling pressure, which means the $9.95–$40.84 range's lower bound becomes a sharper test of the thesis. Sentiment at 58/100 (neutral) and price at $10.60 (near 52-week lows) don't yet suggest stabilization is imminent.
Company Insights: FMC Corporation (FMC)
FMC Corporation operates as a global agricultural sciences company, focusing on the development and sale of crop protection products. Its portfolio includes insecticides, herbicides, and fungicides designed to enhance crop yields and quality for farmers worldwide. The company's long history, dating back to 1883, underpins its established presence in diverse agricultural markets.
Recent financial performance shows a mixed pattern against analyst expectations, with earnings beats in Q1, Q2, and Q3 of 2025, followed by a slight miss in Q4 2025. This variability suggests a need for investors to closely monitor upcoming quarterly results for consistent performance trends. The company's forward outlook for Q1 2026 projects a negative EPS, followed by a positive outlook for Q2 2026, indicating potential seasonal fluctuations.
Strategic developments are shaping FMC's future outlook, including the promising dual mode of action for its Rimisoxafen product, which could bolster its competitive standing. However, the company faces external pressures, such as evolving domestic rare earth metal conversion capabilities and potential shifts away from China's dominance in this area, which may influence raw material costs. Additionally, recent initiation of coverage with a SELL rating by Argus Research highlights areas of concern that management will need to address.
Product Innovation
FMC's Rimisoxafen product demonstrates potential with its dual mode of action, aiming to strengthen its market position.
The company's core business relies on a comprehensive portfolio of insecticides, herbicides, and fungicides to combat agricultural threats.
Innovation in crop protection is crucial for farmers seeking to maximize productivity and crop quality in a challenging environment.
Market Position
FMC serves diverse agricultural markets across North and Latin America, Europe, the Middle East, Africa, and Asia.
Distribution is managed through direct sales, partnerships, and independent networks, ensuring broad customer reach.
The company's long operating history since 1883 provides a foundation of experience in the agricultural sciences sector.
Financial Performance
Recent quarters show a pattern of earnings beats in early 2025 followed by a slight miss in Q4 2025.
Forward estimates for Q1 2026 indicate a negative EPS, with a positive outlook projected for Q2 2026.
Investors will monitor upcoming results to assess the consistency of performance against analyst expectations.
Strategic Risks
Argus Research initiated coverage with a SELL rating, citing concerns across management, safety, and growth.
Shifts in domestic rare earth metal conversion capabilities and reduced reliance on China could impact raw material costs.
Navigating supply chain dynamics for critical materials remains a key challenge for the company.
Positioning FMC
FMC Corporation's stock may appeal to investors seeking exposure to the agricultural sciences sector and crop protection innovation. Consideration for adding to positions could arise if the company demonstrates consistent execution against its product development pipeline and addresses concerns raised by recent analyst ratings. Conversely, reducing exposure might be warranted if performance trends continue to miss expectations or if supply chain disruptions significantly impact profitability.
FMC Competitive Positioning
FMC Corporation (FMC) is tracked alongside these names in Agricultural Inputs on DailyIQ.
Analyst Price Targets for FMC
Here's where sell-side analysts stand on FMC right now, based on the latest ratings DailyIQ has tracked.
Reflects the most recently tracked analyst ratings for FMC and may lag real-time updates. Not a recommendation to buy or sell.
Risk Factors
FMC Corporation faces risks primarily tied to agricultural market dynamics, regulatory shifts, and operational execution. Investors should monitor these factors as they can significantly impact the company's financial performance and stock valuation.
- Product Development
FMC's success hinges on its ability to innovate and bring new crop protection products to market. Delays or failures in clinical trials or regulatory approval for new compounds like Rimisoxafen could hinder revenue growth. This risk materializes if R&D pipelines underperform or face unexpected setbacks.
- Input Costs
The company's profitability is sensitive to fluctuations in the cost of raw materials and manufacturing inputs. Shifts in global supply chains, particularly concerning rare earth metals or other critical components previously sourced from China, could increase production expenses. This risk becomes significant if supply disruptions or geopolitical events drive up input prices.
- Analyst Downgrades
Negative sentiment from influential analysts can impact investor perception and stock price. Argus Research's recent SELL rating, citing concerns across management, safety, and growth, highlights this risk. Such downgrades can lead to increased selling pressure if management does not effectively address the cited issues.
- Agricultural Demand
FMC's revenue is directly linked to farmer spending on crop protection products, which can be influenced by commodity prices and weather patterns. A downturn in agricultural markets or adverse weather conditions could reduce demand for FMC's offerings. This risk materializes during periods of low crop prices or widespread drought/flooding.
- Regulatory Environment
The agricultural inputs industry is subject to stringent and evolving regulatory approvals for its products. Changes in environmental regulations or product registration requirements in key markets could impact FMC's ability to sell its existing portfolio or launch new ones. This risk is present whenever new regulations are proposed or enacted globally.
What Moves FMC Stock?
FMC Corporation's stock performance is primarily driven by the demand for its crop protection products and its ability to navigate evolving agricultural markets. Investor focus remains on product innovation, competitive positioning, and the company's financial results relative to expectations.
Crop Protection Demand
FMC develops and markets insecticides, herbicides, and fungicides essential for modern agriculture, helping farmers combat pests and diseases. The demand for these products is directly tied to global agricultural output and farmer spending, which can fluctuate based on commodity prices and weather patterns.
Strong sales of FMC's core crop protection portfolio translate into higher revenues and profitability. Conversely, any slowdown in farmer spending or increased competition can pressure sales volumes and impact the stock's valuation.
Product Innovation
The company's commitment to research and development, exemplified by products like Rimisoxafen with its dual mode of action, is crucial for maintaining a competitive edge. Innovation allows FMC to offer differentiated solutions that address emerging pest resistance and regulatory challenges.
Successful product launches and pipeline advancements can lead to market share gains and premium pricing, positively influencing investor sentiment and the stock price. Delays or failures in innovation, however, can create headwinds and raise concerns about future growth prospects.
Geopolitical & Supply Chain
FMC operates globally and is subject to geopolitical shifts and supply chain dynamics, such as the evolving domestic rare earth metal conversion capabilities moving away from China. These factors can impact raw material costs and the availability of key inputs for manufacturing.
Disruptions or cost increases related to supply chains can squeeze profit margins and affect production schedules, potentially leading to negative stock reactions. Conversely, successful diversification of supply sources or cost efficiencies can be viewed favorably by the market.
Key insight: FMC's stock is sensitive to the cyclicality of agricultural spending and the success of its innovation pipeline. Investors closely monitor the company's ability to deliver on earnings expectations and adapt to global supply chain dynamics.
Key Metrics for FMC
FMC Corporation's performance hinges on its ability to innovate and effectively deploy crop protection solutions globally. Investors should monitor key operational and financial metrics to gauge the company's market position and growth trajectory.
Revenue Growth: Measures the year-over-year increase in FMC's total sales. Stronger growth indicates successful product adoption and market penetration; declining revenue suggests competitive pressures or market saturation. This is crucial for FMC as it reflects demand for its agricultural inputs and overall business health.
Gross Profit Margin: Indicates the percentage of revenue remaining after accounting for the cost of goods sold. Expanding margins signal efficient production and pricing power for FMC; contracting margins suggest rising input costs or pricing challenges. This metric is vital for assessing FMC's operational efficiency and profitability.
R&D Investment: Tracks the amount FMC spends on research and development for new crop protection products. Increased R&D spending signals a commitment to innovation and future growth; a decrease could indicate a slowdown in pipeline development. This is important for FMC's long-term competitive advantage in the agricultural sciences sector.
Inventory Turnover: Measures how many times FMC's inventory is sold and replaced over a period. A higher turnover generally indicates efficient inventory management and strong sales; a declining rate may suggest slowing demand or excess stock. This matters for FMC by impacting working capital and the risk of product obsolescence.
Geographic Sales Mix: Analyzes revenue contribution from different regions (e.g., North America, Latin America, Europe, Asia). A balanced or growing mix in key agricultural markets is positive; over-reliance on one region poses risks. This is important for FMC to understand market diversification and exposure to regional agricultural cycles and regulations.
FMC Recent Earnings History
- Q4 2025
EPS: $1.2 actual vs $1.21 estimate (miss) · Revenue: $1,083M actual vs $1,162M estimate
- Q3 2025
EPS: $0.89 actual vs $0.85 estimate (beat) · Revenue: $542M actual
- Q2 2025
EPS: $0.69 actual vs $0.62 estimate (beat) · Revenue: $1,050M actual
- Q1 2025
EPS: $0.18 actual vs $0.09 estimate (beat) · Revenue: $791M actual
- Q4 2024
EPS: $1.79 actual vs $1.6 estimate (beat) · Revenue: $1,224M actual
Frequently Asked Questions About FMC
Is FMC Corporation (FMC) stock a good investment?
FMC Corporation's investment appeal hinges on its position as a global agricultural sciences company. The bull case centers on its ability to provide farmers with innovative crop protection solutions, such as insecticides, herbicides, and fungicides, to enhance yields and quality. Investors may consider FMC's market reach across various agricultural regions and its long history in the industry.
What drives FMC Corporation (FMC) stock price?
The stock price of FMC Corporation is primarily influenced by agricultural commodity prices, global weather patterns, and farmer spending on crop inputs. Demand for FMC's insecticides, herbicides, and fungicides is closely tied to planting seasons and pest/disease pressures. Additionally, regulatory changes affecting agricultural chemicals and the company's success in new product development and market penetration play significant roles.
Does FMC Corporation (FMC) pay a dividend?
Yes, FMC Corporation typically pays a quarterly dividend to its shareholders. The company has a history of returning capital to investors through dividends, reflecting its financial stability and commitment to shareholder value. Investors interested in dividend income should review the latest dividend declarations and payout history for current details.
What are the risks of investing in FMC Corporation (FMC)?
Risks associated with FMC Corporation include exposure to agricultural cycles, adverse weather events, and the potential for increased competition. Regulatory hurdles and changing environmental policies can impact product development and sales. Furthermore, dependence on key crop markets and potential supply chain disruptions for raw materials are also factors to consider.
How is FMC Corporation (FMC) valued?
Valuation for FMC Corporation often involves comparing its price-to-earnings (P/E) ratio and other multiples against industry peers and its historical averages. Analysts also assess its enterprise value to EBITDA and price-to-sales ratios. The company's future growth prospects, particularly in its key product segments and emerging markets, are critical inputs for valuation models.
What is FMC Corporation's (FMC) investment thesis?
The investment thesis for FMC Corporation revolves around its role in global food security and agricultural productivity. As the world population grows, demand for efficient crop protection solutions is expected to increase. FMC's focus on innovation in insecticides, herbicides, and fungicides, coupled with its global presence, positions it to benefit from these long-term trends.
What is FMC Corporation's (FMC) outlook for new products like Rimisoxafen?
FMC Corporation's development of new products, such as Rimisoxafen with its dual mode of action, is a key growth driver. Positive clinical or field trial results and successful market introductions can significantly boost revenue and market share. Investors will monitor the progress and commercialization of these innovations as indicators of future performance.
How does FMC Corporation (FMC) manage supply chain risks, especially concerning rare earth metals?
FMC Corporation navigates supply chain risks by diversifying its sourcing and exploring domestic conversion capabilities for critical materials. The company's efforts to reduce reliance on single geographic sources, like China for rare earth metals, aim to ensure more stable raw material costs and availability. This strategic approach is crucial for maintaining production efficiency and competitive pricing.
What impact does analyst coverage, like Argus Research's SELL rating, have on FMC (FMC) stock?
Analyst ratings and reports can influence investor sentiment and short-term stock price movements for FMC Corporation. A SELL rating from a reputable firm like Argus Research may prompt investors to re-evaluate the company's fundamentals, management, and growth prospects. Investors should consider such ratings within the broader context of FMC's operational performance and market conditions.
How does FMC Corporation (FMC) aim to improve farmer productivity?
FMC Corporation aims to improve farmer productivity by offering a comprehensive suite of crop protection products designed to combat pests, weeds, and diseases effectively. Their research and development efforts focus on creating advanced formulations and novel active ingredients that provide superior efficacy and crop safety. By helping farmers protect their crops, FMC contributes to higher yields and better crop quality.
Learn More
Understanding MACD: A Beginner's Guide Learn how MACD crossovers, histogram momentum, and divergence can help you read trend shifts.
Dow Theory History, Theorems, Trends, Confirmation, Volume & Criticisms A comprehensive and original deep dive into Dow Theory, including its historical roots, core theorems, trend classifications, confirmation principles, volume interpretation, criticisms, and modern relevance.
Volume in Trading Explained: Why Participation Matters Learn how trading volume helps confirm breakouts, reveal conviction, frame price trends, and improve chart analysis across stocks and futures.
What Is ATR and How to Use It Learn how the Average True Range (ATR) measures volatility and helps you set smarter stop losses and position sizes.
Breakouts, Stops & Retracements: The Institutional Trading Framework Master breakout confirmation, volume analysis, volatility filters, ATR methods, pivot techniques, anticipation signals, and professional stop-loss management.
Break of Structure (BOS) and Change of Character (CHoCH) Explained Learn how Break of Structure (BOS) and Change of Character (CHoCH) reveal trend continuation and reversals - and how smart money traders use them with liquidity and imbalances.
Recent News Coverage
Most recent articles, ranked by recency (click to expand).